Exactly Zmans - management don't need the big contracts to attract the big investor money, they only need to prove this model is working, Roche recently wrote a big cheque for Accuchek - so they could include it in their portfolio, that was also a Phillip Daffas ideal https://www.roche.com/media/store/releases/med-cor-2017-06-30.htm
No prizes for guessing the exit strategy here
EPT Price at posting:
5.5¢ Sentiment: Buy Disclosure: Held
